ArticleMethods in molecular biology (Clifton, N.J.)2025
A Draft Genome Assembly for the Neglected Tropical Fungal Disease Pathogen Emarellia grisea and Comparison to Other Pleosporalean Agents Causing Eumycetoma in Humans.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycetoma is a neglected tropical disease, characterized by slowly evolving tumorous subcutaneous masses containing either bacteria (e.g., Actinomycetoma) or fungi (e.g., Eumycetoma; Madura foot). The fungal agents of mycetoma, including several genera belonging to the Pleosporales order of Ascomycetes, were designated high-priority pathogens in the WHO Fungal Priority Pathogens List of 2023 to signal the need for additional research and development and public health action. Despite this, many of the fungal causative agents are poorly described, especially in terms of the genomic basis for disease, their epidemiology, and evolutionary history. Recently, the new genus Emarellia was described, including two sister species, E. grisea and E. paragrisea. To gain insights into the virulence and/or pathogenicity features of eumycetoma, we describe the first genome assembly and gene annotation for Emarellia grisea and compare this genome assembly to those currently available for other agents of eumycetoma and close relatives, Madurella mycetomatis and Trematosphaeria pertusa. We also describe the gene annotation for the genome assembly of Nigrograna (formerly Biatriospora) mackinnonii, which hitherto lacked annotation. Our genome assembly comprises 691 contigs representing 28.23 Mb of sequence, with very low repeat content. Genes uniquely encoded by E. grisea included an enrichment of secretion signals, suggesting possible new virulence factors. We also found that E. grisea produces a diverse array of endo- and exopeptidases, which may contribute to its virulence and drug resistance. We anticipate that our genomic resource and analysis will benefit future studies on the genomic basis for pathogenicity in neglected fungal agents causing eumycetoma or similar subcutaneous lesions in humans.
Indexed as
Identifiers
40736901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.